ブックタイトル血管内留置カテーテル由来感染の予防のためのCDCガイドライン 2011｜株式会社メディコン

概要

血管内留置カテーテル由来感染の予防のためのCDCガイドライン 2011｜株式会社メディコン

227. Mack D, Davies AP, Harris LG, Rohde H, Horstkotte MA, Knobloch JK. Microbial interactions inStaphylococcus epidermidis biofilms. Anal Bioanal Chem 2007; 387:399?408.228. von Eiff C, Peters G, Heilmann C. Pathogenesis of infections due to coagulase-negative staphylococci.Lancet Infect Dis 2002; 2:677?85.229. Zhu Y, Weiss EC, Otto M, Fey PD, Smeltzer MS, Somerville GA. Staphylococcus aureus metabolism in abiofilm: the influence of arginine on polysaccharide intercellular adhesin synthesis, biofilm formation, andpathogenesis. Infect Immun 2007; 75:4219?26.230. Murga R, Miller JM, Donlan RM. Biofilm formation by gram-negative bacteria on central venous catheterconnectors: effect of conditioning films in a laboratory model. J Clin Microbiol 2001; 39:2294?7.231. Douglas LJ. Candida biofilms and their role in infection. Trends Microbiol 2003; 11:30?6.232. Donlan RM. Biofilms: microbial life on surfaces. Emerg Infect Dis 2002; 8:881?90.233. Dunne WM Jr., Burd EM. The effects of magnesium, calcium, EDTA, and pH on the in vitro adhesion ofStaphylococcus epidermidis to plastic. Microbiol Immunol 1992; 36:1019?27.234. Ozerdem Akpolat N, Elci S, Atmaca S, Akbayin H, Gul K. The effects of magnesium, calcium and EDTA onslime production by Staphylococcus epidermidis strains. Folia Microbiol (Praha) 2003; 48:649?53.235. Banin E, Brady KM, Greenberg EP. Chelator-induced dispersal and killing of Pseudomonas aeruginosacells in a biofilm. Appl Environ Microbiol 2006; 72:2064?9.236. Donlan RM. Role of biofilms in antimicrobial resistance. ASAIO J 2000; 46:S47?52.237. Farber BF, Kaplan MH, Clogston AG. Staphylococcus epidermidis extracted slime inhibits the antimicrobialaction of glycopeptide antibiotics. J Infect Dis 1990; 161:37?40.238. Branchini ML, Pfaller MA, Rhine-Chalberg J, Frempong T, Isenberg HD. Genotypic variation and slimeproduction among blood and catheter isolates of Candida parapsilosis. J Clin Microbiol 1994; 32:452?6.239. Sanders RA, Sheldon GF. Septic complications of total parenteral nutrition. A five year experience. Am JSurg 1976; 132:214?20.240. Ryan JA Jr., Abel RM, Abbott WM, et al. Catheter complications in total parenteral nutrition. A prospectivestudy of 200 consecutive patients. N Engl J Med 1974; 290:757?61.241. Murphy LM, Lipman TO. Central venous catheter care in parenteral nutrition: a review. JPEN J ParenterEnteral Nutr 1987; 11: 190?201.242. Armstrong CW, Mayhall CG, Miller KB, et al. Prospective study of catheter replacement and other riskfactors for infection of hyperalimentation catheters. J Infect Dis 1986; 154:808?16.243. Garland JS, Dunne WM Jr., Havens P, et al. Peripheral intravenous catheter complications in critically illchildren: a prospective study. Pediatrics 1992; 89:1145?50.244. Garland JS, Nelson DB, Cheah TE, Hennes HH, Johnson TM. Infectious complications during peripheralintravenous therapy with Teflon catheters: a prospective study. Pediatr Infect Dis J 1987; 6:918?21.245. Breschan C, Platzer M, Jost R, Schaumberger F, Stettner H, Likar R. Comparison of catheter-relatedinfection and tip colonization between internal jugular and subclavian central venous catheters in surgicalneonates. Anesthesiology 2007; 107:946?53.246. Deshpande KS, Hatem C, Ulrich HL, et al. The incidence of infectious complications of central venouscatheters at the subclavian, internal jugular, and femoral sites in an intensive care unit population. Crit CareMed 2005; 33:13?20; discussion 234?5.247. Durbec O, Viviand X, Potie F, Vialet R, Albanese J, Martin C. A prospective evaluation of the use of femoralvenous catheters in critically ill adults. Crit Care Med 1997; 25:1986?9.61